 Deciphera Pharmaceuticals Inc NASDAQ: DCPH has priced an underwritten public offering of 5.25 million shares at 10.00 per share, for gross proceeds of 150 million. The offer price represents a discount of 3.5 from the last close price of 10.36 on Tuesday. 